A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes
IntroductionThe etiology of Canine Diabetes Mellitus (CDM) is poorly understood but findings like increased CD3+CD4+CD40+ pathogenic effector T cells (Th40 cells), support an autoimmune contribution. Despite insulin supplementation and possible residua…